RECURSION PHARMACEUTICALS, INC.

RXRX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001601830-26-000045
Filing date: Mar 4, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Borgeson Blake (Director)
SEC Filing link

Summary

Type

Sell

Net shares

-170,000

% of shares

-2.64%

Amount (USD)

$588,200

Insider confidence score

20.0 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Class A Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-170,000.0

Price per Share

$3.46

Amount (USD)

$588,200.00

Acquired/Disposed

Disposed

Shares Owned Before

6,429,863.0

Shares Owned After

6,259,863.0

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.